Close

Maxim Affirms Onconova Therapeutics (ONTX) at 'Buy' Following End-of-Phase 2 Meeting w/ FDA

Go back to Maxim Affirms Onconova Therapeutics (ONTX) at 'Buy' Following End-of-Phase 2 Meeting w/ FDA